Nektar to Announce Financial Results for the Second Quarter 2021 on Thursday, August 5, 2021, After Close of U.S.-Based Financial Markets

Nektar Therapeutics (Nasdaq: NKTR) will announce its Q2 2021 financial results on August 5, 2021, after U.S. markets close.

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) will announce its Q2 2021 financial results on August 5, 2021, after U.S. markets close. The conference call, hosted by CEO Howard Robin, will commence at 5:00 p.m. ET. Investors can access the press release and the live webcast via the company’s website, with a replay available until September 5, 2021. Nektar is focused on developing investigational medicines in oncology, immunology, and virology and operates in San Francisco, Alabama, and India.

Argus Session date unavailable

+2.14% session move Open Argus

Details

News Market Reaction – NKTR

The recorded move for NKTR in the trading session of this news was +2.14%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO, July 27, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2021 on Thursday, August 5, 2021, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through September 5, 2021.

To access the conference call, follow these instructions:

Dial: (877) 881-2183 (U.S); (970) 315-0453 (international)
Conference ID: 4576644 (Nektar Therapeutics is the host)

About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contacts:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-second-quarter-2021-on-thursday-august-5-2021-after-close-of-us-based-financial-markets-301342451.html

SOURCE Nektar Therapeutics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Nektar Therapeutics announce its Q2 2021 financial results?

Nektar Therapeutics will announce its Q2 2021 financial results on August 5, 2021, after the close of U.S.-based financial markets.

What time is the Nektar Therapeutics conference call for Q2 2021 results?

The conference call will start at 5:00 p.m. Eastern Time on August 5, 2021.

How can I access the Nektar Therapeutics financial results conference call?

You can access the conference call by dialing (877) 881-2183 in the U.S. or (970) 315-0453 internationally, using the Conference ID 4576644.

Will there be a replay of the Nektar Therapeutics conference call?

Yes, the web broadcast of the conference call will be available for replay until September 5, 2021.

What is the focus of Nektar Therapeutics?

Nektar Therapeutics focuses on developing investigational medicines in oncology, immunology, and virology, alongside a portfolio of approved partnered medicines.